RFG Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

RFG Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Buy	+7,063	New	+$955K	0.02%	536
2026 Q1	–	Sell	-1,728	Closed	-$211K	–	1116
2025 Q4	$211K	Sell	1,728 -679	-28%	-$77.9K	﹤0.01%	937
2025 Q3	$241K	Sell	2,407 -100	-4%	-$9.01K	0.01%	876
2025 Q2	$208K	Buy	+2,507	New	+$200K	﹤0.01%	885
2024 Q3	–	Sell	-2,337	Closed	-$217K	–	780
2024 Q2	$217K	Buy	2,337 +24	+1%	+$2.15K	0.01%	662
2024 Q1	$219K	Buy	+2,313	New	+$215K	0.01%	672
2023 Q4	–	Sell	-2,958	Closed	-$216K	–	688
2023 Q3	$216K	Buy	+2,958	New	+$236K	0.01%	586
2023 Q1	–	Sell	-2,552	Closed	-$231K	–	662
2022 Q4	$231K	Buy	+2,552	New	+$207K	0.01%	564
2022 Q3	–	Sell	-2,689	Closed	-$248K	–	642
2022 Q2	$248K	Buy	2,689 +123	+5%	+$9.23K	0.01%	494
2022 Q1	$231K	Buy	2,566 +6	+0.2%	+$554	0.01%	462
2021 Q4	$287K	Buy	+2,560	New	+$309K	0.02%	406
2020 Q3	–	Sell	-1,827	Closed	-$204K	–	426
2020 Q2	$204K	Buy	+1,827	New	+$180K	0.03%	366

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

RFG Advisory's XBI Position: Q2 2026 in Review

RFG Advisory opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 7,063 shares worth $1.12M. The stake represents 0.02% of the portfolio and ranks #536 among its holdings. This is a return to the name: RFG Advisory previously reported a position in XBI as recently as Q4 2025.

RFG Advisory first reported a position in XBI in Q2 2020 and has held it in 12 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

RFG Advisory held 7,063 shares of State Street SPDR S&P Biotech ETF worth $1.12M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new RFG Advisory position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #536 holding.
RFG Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 12 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.